feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Medicine Delivery: Convenience or Crisis?

Medicine Delivery: Convenience or Crisis?

16 Dec, 2025

•

Summary

  • Quick commerce platforms now offer prescription medicine delivery.
  • Antibiotic misuse is a significant concern with online pharmacies.
  • Regulatory gaps expose patients to counterfeit and habit-forming drugs.
Medicine Delivery: Convenience or Crisis?

Quick commerce platforms are expanding into prescription medicine delivery, offering integrated doctor consultations and rapid delivery services in select cities. This trend, while promising convenience for busy individuals, is raising alarms within the medical community regarding potential overprescription of antibiotics and symptom-focused treatments. India already faces a severe antibiotic resistance crisis, with a high percentage of prescriptions deemed unnecessary, a problem potentially worsened by the speed and accessibility of online pharmacies.

The ease of obtaining medicines online bypasses crucial clinical considerations and patient counseling, which are vital for managing chronic conditions and preventing the misuse of antibiotics. Patients themselves contribute by viewing antibiotics as quick fixes and often failing to complete prescribed courses, further fueling antimicrobial resistance. This burgeoning e-pharmacy sector currently operates within a regulatory vacuum, leaving patients vulnerable to counterfeit drugs and uncontrolled access to habit-forming substances.

trending

Indigo flight bomb threat

trending

Prince Albert medical procedure

trending

Australian Open Sinner, Alcaraz Dominate

trending

India vs New Zealand decider

trending

India vs New Zealand ODI

trending

Kohli, Yadav visit Ujjain temple

trending

Gambhir blasted for selection errors

trending

iPhone 18 Pro details leaked

trending

JioHotstar entertainment watch time grew

trending

Chopra on Rohit Sharma criticism

While telemedicine and e-pharmacies offer benefits like improved accessibility and price transparency, their growth must be matched by stringent regulatory frameworks. A clear legal structure is essential to ensure that these platforms prioritize patient safety, ethical prescribing, and professional accountability. Without such measures, the convenience offered by these services risks undermining public health and professional medical standards.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, Blinkit is piloting a program in select locations in Bangalore that allows users to purchase prescription medicines through their platform.
Risks include antibiotic overuse, counterfeit medicines, uncontrolled access to habit-forming drugs, and a breakdown of the doctor-patient relationship due to regulatory gaps.
E-pharmacies can normalize quick prescriptions and symptomatic treatments, potentially increasing unnecessary antibiotic use and contributing to India's high rates of antimicrobial resistance.

Read more news on

Healthside-arrow

You may also like

GLP-1 Drugs: Diet Industry's New Cash Cow?

3 hours ago • 3 reads

article image

AbbVie Eyes Revolution Medicines in Cancer Deal

8 Jan • 71 reads

article image

Teva Stock Soars 45%, But Are Better Buys Lurking?

15 Dec, 2025 • 179 reads

article image

AMR Crisis Worsens: Essential Antibiotics Losing Power

11 Dec, 2025 • 154 reads

Holiday Hazards: Food, Jabs, and Fairy Lights!

2 Dec, 2025 • 219 reads

article image